Let‐7a promotes periodontal bone regeneration of bone marrow mesenchymal stem cell aggregates via the Fas/FasL‐autophagy pathway

Author:

Yang Shiyao123,Gao Jing123,Chen Meng4,Sun Yuting123,Qiao Xin135,Mao Hongchen123,Guo Li123,Yu Yang123ORCID,Yang Deqin123ORCID

Affiliation:

1. Department of Endodontics Stomatological Hospital of Chongqing Medical University Chongqing China

2. Stomatological Hospital of Chongqing Medical University Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences Chongqing China

3. Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education Chongqing China

4. Department of Oral and Maxillofacial Surgery Daping Hospital, Army Medical University Chongqing China

5. Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences Chongqing China

Abstract

AbstractPeriodontal bone regeneration using bone marrow mesenchymal stem cell (BMMSC) transplantation is a promising method; however, the method for osteogenic differentiation of BMMSCs needs to be improved. In this research, we sought to identify the roles of let‐7a in the osteogenesis of BMMSCs and to provide a potential method for periodontal bone regeneration. Our previous study revealed that Fas/FasL is a target of let‐7a. In this study, we demonstrated that let‐7a overexpression significantly enhanced BMMSC‐CAs osteogenesis both in vitro and in vivo. Mechanistically, upregulation of Fas/FasL using the rfas/rfaslg plasmid obstructed the osteogenesis of BMMSCs by inhibiting autophagy. Furthermore, we confirmed that overexpression of let‐7a activated autophagy and alleviated the inhibited osteogenesis by the autophagy inhibitor 3‐MA and the rfas/rfaslg plasmid of BMMSCs. In general, our findings showed that let‐7a promoted the osteogenesis of BMMSCs through the Fas/FasL‐autophagy pathway, suggesting that the application of let‐7a in BMMSC‐CAs based periodontal bone regeneration could be a promising strategy.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3